ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China flag China · Delayed Price · Currency is CNY
10.37
-0.39 (-3.62%)
Nov 13, 2026, 3:00 PM CST

SHA:600479 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
356.64286.29230.76320.41302.51302.06
Depreciation & Amortization
106.07106.0799.65103.6595.685.93
Other Amortization
17.9717.9720.918.5316.816.22
Loss (Gain) From Sale of Assets
-1.88-1.88-0.5---33.54
Asset Writedown & Restructuring Costs
0.60.64.690.94-0.170.43
Loss (Gain) From Sale of Investments
-46.6-46.6-16.22-15.87-19.65-26.41
Provision & Write-off of Bad Debts
1.841.845.6117.842.17-0.29
Other Operating Activities
42.396.1378.8379.2888.1775.41
Change in Accounts Receivable
-180.78-180.7818.73-8.69-163.72275.85
Change in Inventory
-8.47-8.4744.6162.29-51.22-52.4
Change in Accounts Payable
244.4244.4-147.8-132.49465.43-160.39
Change in Other Net Operating Assets
-35.42-35.4260.88---
Operating Cash Flow
496.77480.24398.77443.12733.47485.57
Operating Cash Flow Growth
-16.18%20.43%-10.01%-39.59%51.05%-10.47%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-141.6-124.17-47.32-43.99-34.43-71.88
Sale of Property, Plant & Equipment
2.022.220.390.060.230.82
Investment in Securities
-2.88-813.62-700618.4130.07-25.18
Other Investing Activities
4.534.575.7510.8226.3222.9
Investing Cash Flow
-137.92-931-741.18585.29122.15-43.34

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---42.15-60
Long-Term Debt Repaid
--37.08-69.41-74.6-43.83-149.85
Lease Payments
-30.08-30.08-22.46-23.88-28.83-22.28
Net Debt Issued (Repaid)
-34.08-37.08-69.41-32.46-43.83-89.85
Issuance of Common Stock
22-0.4448.59-
Repurchase of Common Stock
-16.56-16.56-16.54-3.38--
Common Dividends Paid
-188.82-152.68-152.82-147.89-248.65-429.53
Other Financing Activities
6.7455.32-11.36-18.72-20.29-1.2
Financing Cash Flow
-230.72-149-250.12-202-264.19-520.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
128.12-599.75-592.54826.4591.43-78.35

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
355.17356.08351.45399.13699.04413.69
Free Cash Flow Growth
-31.56%1.32%-11.95%-42.90%68.97%-7.06%
Free Cash Flow Margin
9.47%9.81%9.68%10.51%17.36%11.29%
Free Cash Flow Per Share
0.730.830.850.941.630.99
Levered Free Cash Flow
239.25345.46226.34241.45716.2333.96
Unlevered Free Cash Flow
239.25345.5227.04242.5717.59335.28
Free Cash Flow After Leases
325.08325.99328.98375.25670.2391.41

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
325.34330.15347.79329.57290.93319.05
Change in Working Capital
19.8319.83-24.94-81.67248.0565.76